For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Take a look at our BETA site and see what we’ve done so far.
Search and browse selected products
Purchase these through your usual distributor
Ground-breaking discoveries in immunology are changing how we understand the immune system and its impact on human health. New therapies targeting eosinophils, macrophages, and T-cells have helped us unveil immune-mediated mechanisms to impede the progression of chronic, elusive diseases like asthma, idiopathic pulmonary fibrosis, and multiple sclerosis.
We feel privileged to be working with researchers at the forefront of immunology research, which brings hope to millions with immune disorders. Our close collaborations with immunology opinion leaders help us provide you with best-in-class reagents for studying established pathways and emerging targets.
With an extensive range of validated recombinant antibodies, dyes, and conjugation kits, we bring you greater flexibility and more confidence in the tools you choose and the results you generate. You can rely on our recombinant antibodies and other proteomic solutions to give you a high level of sensitivity, specificity, and consistency – so you can achieve reproducible outcomes in crucial applications, such as flow cytometry, immunohistochemistry, ELISA, and more.
Infectious diseases are a serious growing threat to global health. In the 21st century alone, many viral diseases have emerged, including SARS, MERS, and SARS-CoV-2. Due to increasing globalization, urbanization, and climate change, pathogens are emerging at an accelerating pace, presenting an unprecedented challenge to public health.
We understand the challenges researchers encounter when unraveling the complexities of infectious diseases. To support you in your infectious disease research, we’ve developed a range of high-quality recombinant reagents, kits, and assay components. Our catalog consists of precision recombinant antibodies identifying potential therapeutic targets for sero-epidemiological studies, and quantifying viral, bacterial, fungal, and protozoal pathogens. We liaise with our network of internal and external experts to validate these antibodies in disease-relevant samples and screen for cross-reactivity in your ELISA, ICC, and IHC experiments.
The prevalence of autoimmune diseases continues to grow each year. From rheumatoid arthritis to rare diseases like lupus and vitiligo, these conditions are rapidly increasing in incidence, thought to be due to processed foods, environmental chemicals, stress, and lack of microbial exposure.
To help you make breakthroughs in this complex field, we provide sensitive and batch-specific reagents & assays. Our portfolio of best-in-class immunoassays and recombinant monoclonal antibodies is designed to support your efforts in investigating human and animal targets.
Whether you are studying classical inflammatory responses or an emerging autoimmune target, our reagents provide reliable and fast results. We leverage the expertise of our academic and industry partners to understand your research needs and provide high-quality solutions tailored to your autoimmune research.
Our bio-active premium grade cytokines, recombinant antibodies, and carrier-free antibodies are just a few of the many tools we provide for western blot, IHC, flow cytometry, ICC, and IP.
The global impact of COVID-19 is a testament to the growing threat that emerging pathogens pose in the 21st century. The constant emergence of new variants presents persistent challenges to the efficacy of vaccine-mediated immunity and the accuracy of diagnostics, highlighting the urgent need for the life sciences community to collaborate to understand the virus better.
We appreciate the value of specific and sensitive reagents for cytokine detection and other immunological targets associated with COVID-19 research. With our immunobiology and flow cytometry expertise, we offer over 250 proteins, antibodies, and ELISAs to develop effective therapeutics, diagnostics, and vaccines for SARS-CoV-2, SARS-CoV, MERS-CoV, and HCoVs.
Contact us at email@example.com to discover how our products and services can support your immunology and infectious disease research.